[1] [1] SUCCONY L, RASSL D M, BARKER A P. Adenocarcinoma spectrum lesions of the lung detection, pathology and treatment strategies[J]. Cancer Treatment Reviews, 2021, 99: 102237.

[2] [2] WANG Q, LI M, YANG M. Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy[J]. Aging (Albany NY), 2020, 12(4): 3312-3339.

[3] [3] HUANG X G, ZHU L H, ZHOU L, et al. Multidisciplinary and comprehensive chinese medicine for advanced non-small cell lung cancer patients: a retrospective study of 855 cases[J]. Chinese Journal of Integrative Medicine, 2021, 27(7): 490-495.

[4] [4] SU X L, WANG J W, CHE H, et al. Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer[J]. Chinese Medical Journal, 2020, 133(24): 2987-2997.

[5] [5] KAWASAKI K, KASAMATSU A, ANDO T. Ginkgolide B regulates CDDP chemoresistance in oral cancer via the platelet-activating factor receptor pathway[J]. Cancers (Basel), 2021, 13(24): 6299.

[6] [6] LOU C, LU H, MA Z. Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway[J]. Biomedicine & Pharmacotherapy, 2019, 109: 563-572.

[7] [7] LI Y, GAO J, YANG X. Combination of curcumin and ginkgolide B inhibits cystogenesis by regulating multiple signaling pathways[J]. Molecular Medicine Reports, 2021, 23(3): 195.

[9] [9] MARYAM A, MEHMOOD T, ZHANG H. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress[J]. Scientific Reports, 2017, 7(1): 6242.

[10] [10] YAN Y, QIAN H, CAO Y. Nuclear factor-B inhibitor BAY11-7082 inhibits gastric cancer cell proliferation by inhibiting Gli1 expression[J]. Oncology Letters, 2021, 21(4): 301.

[11] [11] TSAI J, RDEI D, HOHMANN J, et al. 12-Deoxyphorbol esters induce growth arrestand apoptosis in human lung cancer A549 cells via activation of PKC-/PKD/ERK signaling pathway[J]. International Journal of Molecular Sciences, 2020, 21(20): 7579.

[12] [12] QIN J, XU Z, DENG K. Development of a gene signature associated with iron metabolism in lung adenocarcinoma[J]. Bioengineered, 2021, 12(1): 4556-4568.

[13] [13] KUHN E, MORBINI P, CANCELLIERI A. Adenocarcinoma classification patterns and prognosis[J]. Pathologica, 2018, 110(1): 5-11.

[14] [14] WAN L Q, TAN Y, JIANG M, et al. The prognostic impact of traditional Chinese medicine monomers on tumor-associated macrophages in non-small cell lung cancer[J]. Chinese Journal of Natural Medicines, 2019, 17(10): 729-737.

[15] [15] GUI Y R, ZHANG Y, WANG X Q, et al. Treatment of lung cancer with orally administered chinese herbal medicine: an evidence map between 1970—2020[J]. Chinese Journal of Integrative Medicine, 2022, 28(10): 930-938.

[16] [16] WANG X, SHAO Q H, ZHOU H, et al. Retraction note: ginkgolide B inhibits lung cancer cells promotion via beclin-1-dependent autophagy[J]. BMC Complementary Medicine and Therapies, 2023, 23(1): 251.